Startseite
MK

Über das Mitglied

Biografie

The König group applies Systems Medicine and Systems Biology to study drug metabolism and liver function. We use computational modeling, data science, bioinformatics analysis and machine learning on biological, medical and clinical data. Main research topics are (i) predictive modeling of biomedical systems with special focus on the liver; (ii) development of digital twins using physiologically based pharmacokinetic (PBPK) models, (iii) reproducible and open research, and (iv) FAIR data and workflows. Key projects are the personalized evaluation of liver function tests, multi-scale modeling of the liver, and development of databases and workflows to support reproducible, open and FAIR research. Within our research we generate predictive digital twins of the individual human physiology. Such models can provide important insights in inter-individual differences and personal treatments, e.g., individual dosing of medication or effect of lifestyle factors on drug metabolism.

Ausbildung

  • Charité - Universitätsmedizin Berlin
    Abschluss PhD
    Studienrichtung Institute of Biochemistry, Computational Systems Biochemistry
    Startdatum 01/2012
    Enddatum 01/2015

Berufserfahrung

UO

Head of Computational Biomechanics Group

University of Stuttgart •

01/2025 – 01/2026 •

Institute of Structural Mechanics and Dynamics in Aerospace Engineering

UO

Associate Professor of Pharmacoepidemiology and Data Science

University of Southern Denmark •

01/2026 – 01/2026 •

Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine

HZ

Head of Systems Medicine of Liver Group

Humboldt-Universität zu Berlin •

01/2016 – 01/2025 •

Institute for Theoretical Biology

Matthias König — Professor of Metabolic Inflammation and Carcinogenesis of the Liver | PharmaCountry